site stats

Geron financials

WebGet the latest Geron Corporation (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebMar 16, 2024 · Welcome to the Geron Corporation fourth-quarter and year-end 2024 earnings conference call. I am Aron Feingold, Geron's vice president of investor relations and corporate communications. I'm ...

Geron Corporation - AnnualReports.com

WebGeron General Information. Description. Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood … WebGet the detailed quarterly/annual income statement for Geron Corporation (GERN). Find out the revenue, expenses and profit or loss over the last fiscal year. cpu locker plastic https://carlsonhamer.com

Geron to Present at Upcoming Investor Conferences in April

WebDec 23, 2004 · Detailed price information for Geron Corp (GERN-Q) from The Globe and Mail including charting and trades. WebApr 12, 2024 · FOSTER CITY, Calif., April 12, 2024--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief ... WebGeron Corporation DVAX: Raising target price to $11.00 DYNAVAX TECHNOLOGIES CORP has an Investment Rating of HOLD; a target price of $11.000000; an Industry … Find the latest Geron Corporation (GERN) stock discussion in Yahoo Finance's … Geron (GERN) closed the most recent trading day at $2.30, moving -1.71% … Find out all the key statistics for Geron Corporation (GERN), including valuation … See the company profile for Geron Corporation (GERN) including business … Discover historical prices for GERN stock on Yahoo Finance. View daily, weekly or … See Geron Corporation (GERN) stock analyst estimates, including earnings … Find out the direct holders, institutional holders and mutual fund holders for … Get the detailed quarterly/annual income statement for Geron Corporation … View the basic GERN option chain and compare options of Geron Corporation … See Geron Corporation (GERN) Environment, Social and Governance … distance white river to phabeni gate

Geron Corporation Reports Fourth Quarter and Full Year 2024 …

Category:Geron to Announce Fourth Quarter and Full-Year 2024 Financial …

Tags:Geron financials

Geron financials

Geron Corporation (GERN) Stock Price & News - Google Finance

WebMar 16, 2024 · Geron will host a conference call at 4:30 p.m. ET on Thursday, March 16, 2024 to discuss business updates, expected upcoming milestones and fourth quarter and full year 2024 financial results. WebSee the company profile for Geron Corporation (GERN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Geron financials

Did you know?

WebMar 16, 2024 · Positive Phase 3 Top-Line Results in Lower Risk MDS Reported in January 2024 Planned 2024 Regulatory Submissions in the U.S. and EU On Track Preparations for Potential Commercial Launch in U.S. Ongoing Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, …

WebGeron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, … WebApr 6, 2024 · A high-level overview of Geron Corporation (GERN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

WebMar 9, 2024 · Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ET the same day. FOSTER CITY, Calif., March 09, 2024--Geron Corporation (Nasdaq: GERN ... WebApr 10, 2024 · Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in ...

Web1 day ago · Thursday, April 20 at 10:15 a.m. ET. Stifel 2024 Virtual Targeted Oncology Days. Tuesday, April 25 at 2:00 p.m. ET. A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron’s website under Events. Following each scheduled conference event, the related webcast will be …

Web20 hours ago · Financials Financial Overview ; Income Statements ; Balance Sheet ; Cash flow Statements ... Geron (GERN) Receives a New Rating from Goldman Sachs 03/28/23-5:26AM EST TipRanks distance wichita ks to liberal ksWebMar 27, 2024 · Detailed financial statements for Geron (GERN), including the income statement, balance sheet, and cash flow statement. ... Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual and quarterly reports submitted to the Securities and Exchange Commission (SEC). Sections ... cpu location in desktopWebApr 10, 2024 · Finance. The trading price of Geron Corporation (NASDAQ:GERN) closed higher on Thursday, April 06, closing at $2.05, 2.50% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.97 and $2.085. In examining the 52-week price action we see that the stock hit a 52 … cpu locking leverWebJun 22, 2024 · Geron's market cap is currently ―. The company's EPS TTM is $-0.366; its P/E ratio is -5.60; Geron is scheduled to report earnings on May 8, 2024, and the … distance wilcannia to hayWebGeron (GERN) closed the most recent trading day at $2.30, moving -1.71% from the previous trading session. Simply Wall St. Geron Full Year 2024 Earnings: EPS Beats … distance wichita ks to tucumcari nmWebMar 16, 2024 · 1. The following information was filed by Geron Corp (GERN) on Wednesday, January 4, 2024 as an 8K 2.02 statement, which is an earnings press … cpu location on pcWebMay 10, 2024 · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies, today reported financial results for the first quarter ended March 31, 2024, as well as company … distance when earth is farthest from mars